4.8 Article

A photoswitchable GPCR-based opsin for presynaptic inhibition

期刊

NEURON
卷 109, 期 11, 页码 1791-+

出版社

CELL PRESS
DOI: 10.1016/j.neuron.2021.04.026

关键词

-

资金

  1. NIH BRAIN Initiative [R01 MH111520]
  2. NIH [R21 DA049569, K01 DA042219, K01 DK115634, T32DA007278, R35 GM122577, P30DA048736]
  3. Mary Gates Research Fellowship
  4. Scan Design Research Foundation
  5. Hope Center Viral Vectors Core at Washington University School of Medicine

向作者/读者索取更多资源

This study introduces a GPCR-based opsin called parapinopsin (PPO), which can rapidly and reversibly inhibit the release of glutamate, GABA, and dopamine at presynaptic terminals by coupling with G(i/o) signaling cascades. PPO alters reward behaviors in a time-locked and reversible manner in vivo, filling a significant gap in the neuroscience toolkit for rapid and reversible synaptic inhibition.
Optical manipulations of genetically defined cell types have generated significant insights into the dynamics of neural circuits. While optogenetic activation has been relatively straightforward, rapid and reversible synaptic inhibition has proven more elusive. Here, we leveraged the natural ability of inhibitory presynaptic GPCRs to suppress synaptic transmission and characterize parapinopsin (PPO) as a GPCR-based opsin for terminal inhibition. PPO is a photoswitchable opsin that couples to G(i/o) signaling cascades and is rapidly activated by pulsed blue light, switched off with amber light, and effective for repeated, prolonged, and reversible inhibition. PPO rapidly and reversibly inhibits glutamate, GABA, and dopamine release at presynaptic terminals. Furthermore, PPO alters reward behaviors in a time-locked and reversible manner in vivo. These results demonstrate that PPO fills a significant gap in the neuroscience toolkit for rapid and reversible synaptic inhibition and has broad utility for spatiotemporal control of inhibitory GPCR signaling cascades.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据